Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1979-12-20
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jul
|
pubmed:issn |
0305-7453
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
5
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
413-8
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:385579-Cinoxacin,
pubmed-meshheading:385579-Escherichia coli,
pubmed-meshheading:385579-Escherichia coli Infections,
pubmed-meshheading:385579-Humans,
pubmed-meshheading:385579-Microbial Sensitivity Tests,
pubmed-meshheading:385579-Nalidixic Acid,
pubmed-meshheading:385579-Pyridazines,
pubmed-meshheading:385579-Urinary Tract Infections
|
pubmed:year |
1979
|
pubmed:articleTitle |
In vitro susceptibility of urinary isolates of Escherichia coli to cinoxacin.
|
pubmed:publicationType |
Journal Article
|